Proteomic Study Identified Novel Ischemic Stroke Risk Factors


A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins significantly associated with incident ischemic stroke risk, of which 26 are novel. Twenty-six of these associations were replicated in two independent cohorts. Mendelian randomization analyses suggested that MMP12 (matrix metallopeptidase-12) may have a direct protective effect on ischemic stroke risk, while CNTN1 (contactin-1) may have a direct harmful effect. The study profiled 4,954 blood proteins using aptamers in 14,139 participants without prevalent stroke at baseline, with median follow-up of 25 years in ARIC and 12 years in CHS, during which 1,397 participants (10%) experienced an ischemic stroke; study-specific Cox regression models adjusted for ischemic stroke risk factors were combined via fixed-effects meta-analysis and validated in the AGES-Reykjavik and UK Biobank cohorts, where 37 of 44 associations (84%) were directionally concordant and 26 (59%) met replication criteria. These findings highlight novel risk biomarkers and two potential etiologic factors regulated in response to atherosclerosis and obesity, which may inform the development of new preventive therapies for ischemic stroke. Source: https://www.ahajournals.org/

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.